Mymetics Corporation (MYMX)
MYMX Stock Price Chart
Explore Mymetics Corporation interactive price chart. Choose custom timeframes to analyze MYMX price movements and trends.
MYMX Company Profile
Discover essential business fundamentals and corporate details for Mymetics Corporation (MYMX) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
26 Oct 1999
Employees
2.00
Website
https://www.mymetics.comCEO
Ronald Kempers
Description
Mymetics Corporation, a vaccine company, engages in the research and development of vaccines for infectious and life disabling diseases in Switzerland. The company's product pipeline includes various vaccine candidates, such as HIV-1/AIDS, Covid-19, intra nasal influenza, respiratory syncytial virus, malaria, and chikungunya. Mymetics Corporation has a collaboration agreement with Texas Biomedical Research Institute; PATH Malaria Vaccine Initiative and the Laboratory of Malaria Immunology and Vaccinology of the National Institute of Allergy and Infectious Diseases to develop and produce virosome based vaccine formulations for a malaria transmission-blocking vaccine candidate; and Sanofi Pasteur Biologics, LLC to investigate the immunogenicity of influenza vaccines. The company was formerly known as ICHOR Corporation and changed its name to Mymetics Corporation in July 2001. Mymetics Corporation was founded in 1990 and is based in Epalinges, Switzerland.
MYMX Financial Timeline
Browse a chronological timeline of Mymetics Corporation corporate events including earnings releases, dividend announcements, and stock splits.
Stock split effective on 2 Jan 2024
Shares were split 1 : 2000 , changing the number of shares outstanding and the price per share accordingly.
Stock split effective on 29 Dec 2023
Shares were split 1 : 2000 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 20 Nov 2023
EPS came in at -$0.00 , while revenue for the quarter reached $39.01K .
Earnings released on 18 Aug 2023
EPS came in at -$20.00 , while revenue for the quarter reached $219.65K .
Earnings released on 15 May 2023
EPS came in at -$0.01 , while revenue for the quarter reached $3.26K .
Earnings released on 11 Apr 2023
EPS came in at -$20.00 , while revenue for the quarter reached $127.46K .
Earnings released on 14 Nov 2022
EPS came in at -$0.01 , while revenue for the quarter reached $126.95K .
Earnings released on 11 Aug 2022
EPS came in at -$0.01 , while revenue for the quarter reached $310.67K .
Earnings released on 13 May 2022
EPS came in at -$0.01 , while revenue for the quarter reached $536.47K .
Earnings released on 31 Mar 2022
EPS came in at -$20.00 , while revenue for the quarter reached $62.35K .
Earnings released on 12 Nov 2021
EPS came in at -$0.00 , while revenue for the quarter reached $95.18K .
Earnings released on 16 Aug 2021
EPS came in at -$0.00 , while revenue for the quarter reached $188.64K .
Earnings released on 18 May 2021
EPS came in at -$0.00 , while revenue for the quarter reached $3.53K .
Earnings released on 31 Mar 2021
EPS came in at -$0.00 , while revenue for the quarter reached $8.58K .
Earnings released on 13 Nov 2020
EPS came in at -$0.00 , while revenue for the quarter reached $14.09K .
MYMX Stock Performance
Access detailed MYMX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.